P & G Health Ltd

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
6,236.80
-36.75 (-0.59%)
BSENSE

Jun 15, 03:30 PM

BSE+NSE Vol: 10.51 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Standalone Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 14.38% vs 4.57% in Dec 2024

stock-summary

Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is 22.26% vs 3.15% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 12.37% vs 10.85% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is -32.00% vs -3.85% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024

Compare Nine Monthly Results Of P & G Health Ltd With
Markets Mojo
Figures in Cr
Standalone Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,037.52
1,050.09
-12.57
-1.20%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,037.52
1,050.09
-12.57
-1.20%
Raw Material Cost
222.14
75.79
146.35
193.10%
Purchase of Finished goods
48.27
104.03
-55.76
-53.60%
(Increase) / Decrease In Stocks
1.80
14.88
-13.08
-87.90%
Employee Cost
171.70
296.38
-124.68
-42.07%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
272.54
327.60
-55.06
-16.81%
Total Expenditure (Excl Depreciation)
716.45
818.68
-102.23
-12.49%
Operating Profit (PBDIT) excl Other Income
321.07
231.41
89.66
38.75%
Other Income
13.34
6.53
6.81
104.29%
Operating Profit (PBDIT)
334.41
237.94
96.47
40.54%
Interest
0.34
5.58
-5.24
-93.91%
Exceptional Items
0.00
-19.10
19.10
100.00%
Gross Profit (PBDT)
334.07
213.26
120.81
56.65%
Depreciation
17.42
27.57
-10.15
-36.82%
Profit Before Tax
316.65
185.69
130.96
70.53%
Tax
84.34
45.89
38.45
83.79%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
232.31
139.80
92.51
66.17%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
232.31
139.80
92.51
66.17%
Equity Capital
16.60
61.16
-44.56
-72.86%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
0.00
0.00
0.00
Operating Profit Margin (Excl OI)
30.95%
22.04%
0.00
8.91%
Gross Profit Margin
32.20%
20.31%
0.00
11.89%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 1,037.52 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 14.38% vs 4.57% in Dec 2024

Nine Monthly - Standalone Net Profit
Standalone Net Profit 232.31 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 22.26% vs 3.15% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 321.07 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 12.37% vs 10.85% in Dec 2024

Nine Monthly - Interest
Interest 0.34 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is -32.00% vs -3.85% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.95%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024